GECCO_Does_the_patient_suffer_from_at_least_one_chronic_lung_disease
|
GECCO_Does_the_patient_suffer_from_at_least_one_chronic_lung_disease |
|
Duration_of_neutropenia_(with_neutrophil_count_less_than_500_per_µl)
|
Duration_of_neutropenia_(with_neutrophil_count_less_than_500_per_µl) |
|
neutropenia
|
neutropenia |
|
Tetrahydrocannabinol
|
Tetrahydrocannabinol |
|
Current_drug_consumption
|
Current_drug_consumption |
|
401
|
401 |
|
402
|
402 |
|
Husten
|
R05 |
|
SARS CoV 2 symptoms surrogate
|
GECCO_1.2.276.0.76.11.502 |
[Symptome bei SARS-CoV-2 Infektion mittels ICD-10-GM] |
glucagon-like_peptide-1_receptor_agonist
|
glucagon-like_peptide-1_receptor_agonist |
|
hypoglycemic_drug
|
hypoglycemic_drug |
|
Which_oral_antidiabetic_treatment_has_been_used_before_SARS-CoV-2_detection?
|
Which_oral_antidiabetic_treatment_has_been_used_before_SARS-CoV-2_detection? |
|
403
|
403 |
|
Hematology
|
Hematology |
|
How_many_times_a_day
|
How_many_times_a_day |
|
Respiratory_physiotherapy
|
Respiratory_physiotherapy |
|
404
|
404 |
|
Blood_Urea_Nitrogen
|
Blood_Urea_Nitrogen |
|
405
|
405 |
|
Overt_hepatic_encephalopathy_stage_III-IV
|
Overt_hepatic_encephalopathy_stage_III-IV |
|